BETA DRUGS
Back to Balance Sheet
|
BETA DRUGS Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹138 Cr | ₹15 Cr | ₹20 Cr | ₹21 Cr | ₹17 Cr |
What is the latest Total Debt ratio of BETA DRUGS ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹138 Cr |
| Mar2024 | ₹15 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹21 Cr |
| Mar2021 | ₹17 Cr |
How is Total Debt of BETA DRUGS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹138 Cr | 838.45 | |
| Mar2024 | ₹15 Cr | -27.65 | |
| Mar2023 | ₹20 Cr | -1.31 | |
| Mar2022 | ₹21 Cr | 17.97 | |
| Mar2021 | ₹17 Cr | - | |
Compare Total Debt of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,341.9 Cr | -8.9% | -2.5% | 33% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹474,396.0 Cr | 1.8% | 5.6% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,990.0 Cr | 0.5% | 13.1% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,354.0 Cr | -2.7% | 5.1% | 42.4% | Stock Analytics | |
| CIPLA | ₹116,705.0 Cr | 2.1% | -0.6% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹94,790.0 Cr | -4% | -17.5% | -8.6% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -8.9% |
-2.5% |
33% |
| SENSEX | -0.9% |
-0.4% |
-6.1% |
You may also like the below Video Courses